BGI Genomics Co., Ltd. - Enterprise Value
300676.SZ
Price:
$44.33
Market Cap:
$18.54B
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private organizations, both within China and across the globe. Its comprehensive service portfolio includes DNA, RNA, and tailored sequencing options. Additionally, it offers a suite of specialized genetic tests such as non-invasive prenatal testing (NIPT), reproductive health screening, and newborn genetic screening, alongside clinical exome sequencing. BGI Genomics also develops clinical and research-focused solutions for the field of oncology. During the COVID-19...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-07-14
Stock Exchange
SHZ
Ticker
300676.SZ
PE Ratio
[-32.17]
ROE
[-6.63%]
Current Ratio
[2.81]
Dividend Yield
[0%]
Enterprise Value
[16.46B]
Dividend History
The Enterprise Value as of October 2026 (TTM) for BGI Genomics Co., Ltd. (300676.SZ) is 16.46B
According to BGI Genomics Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.46B. This represents a change of 7.46% compared to the average of 15.32B of the last 4 quarters.
BGI Genomics Co., Ltd. (300676.SZ) Historical Enterprise Value (quarterly & annually)
How has 300676.SZ Enterprise Value performed in the past?
The mean historical Enterprise Value of BGI Genomics Co., Ltd. over the last ten years is 27.14B. The current 16.46B Enterprise Value has changed 5.97% with respect to the historical average. Over the past ten years (40 quarters), 300676.SZ's Enterprise Value was at its highest in in the December 2017 quarter at 79.23B. The Enterprise Value was at its lowest in in the September 2016 quarter at 0.
Average
27.14B
Median
19.54B
Minimum
6.36B
Maximum
76.70B
BGI Genomics Co., Ltd. (300676.SZ) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of BGI Genomics Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.11%
Maximum Annual Enterprise Value = 76.70B
Minimum Annual Increase = -70.42%
Minimum Annual Enterprise Value = 6.36B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 16.38B | 18.83% |
| 2024 | 13.79B | -8.13% |
| 2023 | 15.01B | -7.17% |
| 2022 | 16.17B | -46.35% |
| 2021 | 30.13B | -36.02% |
| 2020 | 47.10B | 74.11% |
| 2019 | 27.05B | 19.23% |
| 2018 | 22.69B | -70.42% |
| 2017 | 76.70B | 1.11% |
| 2016 | 6.36B | 2.91% |
BGI Genomics Co., Ltd. (300676.SZ) Average Enterprise Value
How has 300676.SZ Enterprise Value performed in the past?
The current Enterprise Value of BGI Genomics Co., Ltd. (300676.SZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.06B
5-year avg
18.29B
10-year avg
27.14B
BGI Genomics Co., Ltd. (300676.SZ) Enterprise Value vs. Peers
How is 300676.SZ’s Enterprise Value compared to its peers?
BGI Genomics Co., Ltd.’s Enterprise Value is greater than Berry Genomics Co.,Ltd (4.16B), greater than Novogene Co., Ltd. (8.84B), greater than Amoy Diagnostics Co., Ltd. (6.78B), greater than Guangzhou Kingmed Diagnostics Group Co., Ltd. (12.25B), greater than Dian Diagnostics Group Co.,Ltd. (13.97B), greater than Maccura Biotechnology Co.Ltd (5.90B), greater than Shanghai Kehua Bio-engineering Co., Ltd. (3.01B), less than Autobio Diagnostics Co., Ltd. (18.57B), greater than Beijing Strong Biotechnologies, Inc. (7.57B), greater than Beijing Hotgen Biotech Co., Ltd. (7.33B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.16B | $4.14B | |
| 8.84B | $9.16B | |
| 6.78B | $7.63B | |
| 12.25B | $13.62B | |
| 13.97B | $13.12B | |
| 5.90B | $5.72B | |
| 3.01B | $3.12B | |
| 18.57B | $18.91B | |
| 7.57B | $6.99B | |
| 7.33B | $7.55B |
Build a custom stock screener for BGI Genomics Co., Ltd. (300676.SZ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BGI Genomics Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BGI Genomics Co., Ltd. (300676.SZ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BGI Genomics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BGI Genomics Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for BGI Genomics Co., Ltd. (300676.SZ)?
What is the 3-year average Enterprise Value for BGI Genomics Co., Ltd. (300676.SZ)?
What is the 5-year average Enterprise Value for BGI Genomics Co., Ltd. (300676.SZ)?
How does the current Enterprise Value for BGI Genomics Co., Ltd. (300676.SZ) compare to its historical average?